McKinney v. NuScience Corp. CA2/2

CourtCalifornia Court of Appeal
DecidedNovember 25, 2013
DocketB240831
StatusUnpublished

This text of McKinney v. NuScience Corp. CA2/2 (McKinney v. NuScience Corp. CA2/2) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McKinney v. NuScience Corp. CA2/2, (Cal. Ct. App. 2013).

Opinion

Filed 11/25/13 McKinney v. NuScience Corp. CA2/2 NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SECOND APPELLATE DISTRICT

DIVISION TWO

DAVID McKINNEY, B240831 (c/w B244074)

Plaintiff and Appellant, (Los Angeles County Super. Ct. No. BC469493) v.

NuSCIENCE CORPORATION,

Defendant and Respondent.

APPEAL from orders of the Superior Court of Los Angeles County. Alan Rosenfield, Judge. Affirmed.

Law Offices of Stephen Abraham and Stephen E. Abraham for Plaintiff and Appellant.

Jacobson Russell Saltz & Fingerman, Michael J. Saltz, Colby A. Petersen and Blair Schlecter for Defendant and Respondent.

****** David McKinney (appellant) appeals from an order granting NuScience Corporation’s (respondent) special motion to strike a malicious prosecution complaint under the anti-SLAPP statute (Code Civ. Proc., § 425.16).1 Appellant also challenges an order awarding respondent attorney fees in the amount of $129,938.75. We affirm both orders. FACTS AND PROCEDURAL HISTORY The Trade Secret and Ownership Appellant was respondent’s former employee. Respondent is in the business of manufacturing and selling oxygen-based health and beauty products and other mineral supplements. Its primary product is known as CELLFOOD, which is an oxygen and nutrient supplement containing 78 minerals, 34 enzymes, and 17 amino acids. CELLFOOD uses a proprietary water-splitting technology to provide a stream of bio- available oxygen in addition to 129 nutrients directly to the cells. The formula was developed by Everett Storey while he was an owner and officer of Deutrel Laboratories, Inc. Storey willed Deutrel Laboratories and its associated businesses to Lois Ramm. Ramm sold Deutrel Laboratories and its trade secrets to Jerald Rhoten in 1991. Rhoten subsequently assigned the trade secrets to his family-owned company, NuScience. Litigation with the Henkel Family When Ramm died in 2004, her brother, John Henkel, discovered documents containing the trade secret formula, which had been sold to Rhoten in 1991. John subsequently threatened respondent that he would sell or use the trade secret formula unless respondent paid him a large sum of money. Respondent ultimately obtained against John an Iowa State Court permanent restraining order and injunction prohibiting him from using, possessing, controlling or stating that he controlled or possessed respondent’s trade secrets. John was also enjoined from revealing or communicating the

1 SLAPP is an acronym for strategic lawsuits against public participation. (City of Alhambra v. D’Ausilio (2011) 193 Cal.App.4th 1301, 1303, fn. 1.) All further statutory references are to the Code of Civil Procedure unless otherwise indicated.

2 trade secrets to anyone. John was ordered to destroy documents, drawings, or designs containing the ingredients, formula or recipe for CELLFOOD. John has two sons, Robert and Michael Henkel. The two sons claimed to possess documents containing CELLFOOD’s formula. Robert and Michael offered to sell the formula to third parties, including respondent’s customers. Robert began producing his own version of CELLFOOD called Deutrocell, which he sold over the Internet. Michael offered to sell the deuterium sulfate technology. In April 2008, respondent filed a federal action (NuScience Corporation v. Robert Henkel, etc. et al., United States District Court, Central District of California, case No. CV-08-2661-GAF (FFMx) against Robert and Michael for, among other things, misappropriation of trade secrets and federal trademark infringement. Respondent obtained a default judgment against Robert and Michael in the federal action on April 14, 2009. The federal judgment prohibited Robert and Michael from using, possessing, controlling or stating that they controlled or possessed respondent’s trade secrets. They were also enjoined from revealing or communicating the trade secrets to anyone and prohibited from selling respondent’s proprietary trade secret information and formulas to third parties. Notwithstanding the federal judgment and restraining order, Michael offered to sell the technology on the Internet. Robert and Michael currently sell the same or similar product called Choice O2. Litigation with Appellant and Robert Henkel On October 27, 2010, respondent filed a complaint entitled Nuscience Corporation v. David McKinney, et al., Los Angeles County Superior Court, case No. BC443331 (the underlying complaint) against appellant and Robert. The underlying complaint alleged that respondent employed appellant from October 2005 until August 29, 2008. When appellant began working for respondent, he signed a written employment agreement, whereby he agreed to maintain the confidentiality of respondent’s trade secrets and other proprietary information. In August 2008, appellant signed a written separation agreement in which he agreed to a maintain confidentiality on certain matters including trade secrets and other proprietary information.

3 Respondent alleged, on information and belief, that appellant and Robert engaged in communications and conspired to disclose respondent’s trade secrets and other proprietary information. Appellant was alleged to have conspired with Robert to violate the federal judgment and to defame respondent and its business reputation. Appellant allegedly made untrue and disparaging statements about respondent’s business as set forth in e-mail messages, which were attached to the underlying complaint. Respondent sought damages and injunctive relief under the following theories: breach of contract, trade libel, misappropriation of trade secrets; unfair business practices, conspiracy, civil violation of the federal Racketeer Influenced and Corrupt Organizations Act (RICO) (18 U.S.C. § 1961 et seq.) and intentional inference with contract. The trade libel cause of action was based on allegations appellant falsely disparaged respondent by claiming the company did not comply with good manufacturing practices set by the U.S. Food and Drug Administration. Respondent alleged injury to its relationships with customers and a loss of business as a result of appellant’s statements about the production of CELLFOOD. The misappropriation claim was based on appellant’s alleged misappropriation of respondent’s trade secrets by disclosure and use with Robert. The civil RICO claim was predicated on the federal judgment against Robert, which prohibited him from using or disclosing respondent’s trade secret. Respondent alleged that appellant assisted Robert in violating the federal court judgment. On June 3, 2011 the trial court granted discovery motions brought by appellant requesting additional responses. On June 24, 2011, appellant filed a motion for terminating sanctions. Appellant argued respondent’s further responses lacked substance and respondent did not produce any documents which established a factual basis to support its claims against appellant. Respondent opposed the motion contending it had provided all the information it currently had and that the failure to prove a case through limited discovery was not a basis for imposing a terminating sanction. On July 20, 2011, prior to the trial court’s hearing on the motion for terminating sanctions, respondent filed a request to dismiss the underlying complaint without prejudice. In connection with the special motion to strike the malicious prosecution

4 action, respondent explained its motivation for dismissing the underlying action.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Press v. Lucky Stores, Inc.
667 P.2d 704 (California Supreme Court, 1983)
Sheldon Appel Co. v. Albert & Oliker
765 P.2d 498 (California Supreme Court, 1989)
Bertero v. National General Corp.
529 P.2d 608 (California Supreme Court, 1974)
PLCM Group, Inc. v. Drexler
997 P.2d 511 (California Supreme Court, 2000)
Serrano v. Priest
569 P.2d 1303 (California Supreme Court, 1977)
In Re Marriage of Flaherty
646 P.2d 179 (California Supreme Court, 1982)
Briggs v. Eden Council for Hope & Opportunity
969 P.2d 564 (California Supreme Court, 1999)
Lucchesi v. Giannini & Uniack
158 Cal. App. 3d 777 (California Court of Appeal, 1984)
Nichols v. Great American Ins. Companies
169 Cal. App. 3d 766 (California Court of Appeal, 1985)
DeRosa v. Transamerica Title Insurance
213 Cal. App. 3d 1390 (California Court of Appeal, 1989)
Eells v. Rosenblum
36 Cal. App. 4th 1848 (California Court of Appeal, 1995)
Gervase v. Superior Court
31 Cal. App. 4th 1218 (California Court of Appeal, 1995)
Robbins v. Blecher
52 Cal. App. 4th 886 (California Court of Appeal, 1997)
Daniels v. Robbins
182 Cal. App. 4th 204 (California Court of Appeal, 2010)
Fuentes v. Berry
38 Cal. App. 4th 1800 (California Court of Appeal, 1995)
Monterey Plaza Hotel v. Hotel Employees & Restaurant Employees Local 483
82 Cal. Rptr. 2d 10 (California Court of Appeal, 1999)
Villa v. Cole
4 Cal. App. 4th 1327 (California Court of Appeal, 1992)
Sangster v. Paetkau
80 Cal. Rptr. 2d 66 (California Court of Appeal, 1998)
Rusheen v. Cohen
128 P.3d 713 (California Supreme Court, 2006)
Wilson v. Parker, Covert & Chidester
50 P.3d 733 (California Supreme Court, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
McKinney v. NuScience Corp. CA2/2, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mckinney-v-nuscience-corp-ca22-calctapp-2013.